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Scavenger receptorsCell penetrating peptides are efﬁcient tools to deliver various bioactive cargos into cells, but their exact function-
ing mechanism is still debated. Recently, we showed that a delivery peptide PepFect14 condenses oligonucleo-
tides (ON) into negatively charged nanocomplexes that are taken up by cells via class A scavenger receptors
(SR-As). Here we unraveled the uptake mechanism and intracellular trafﬁcking of PF14–ON nanocomplexes in
HeLa cells. Macropinocytosis and caveolae-mediated endocytosis are responsible for the intracellular functional-
ity of nucleic acids packed into nanocomplexes. However, only a negligible fraction of the complexes were traf-
ﬁcked to endoplasmic reticulum or Golgi apparatus— the common destinations of caveolar endocytosis. Neither
were the PF14–SCO nanocomplexes routed to endo-lysosomal pathway, and they stayed in vesicles with slightly
acidic pH, which were not marked with LysoSensor. “Naked” ON, in contrary, was rapidly targeted to acidic ves-
icles and lysosomes. The transmission electron microscopy analysis of interactions between SR-As and PF14–ON
nanocomplexes on ultrastructural level revealed that nanocomplexes localized on the plasmamembrane in close
proximity to SR-As and their colocalization is retained in cells, suggesting that PF14–ONcomplexes associatewith
targeted receptors.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Cell penetrating peptides (CPPs) are gaining popularity as non-viral
delivery vectors for transfecting nucleic acids into cells, including oligo-
nucleotide- based therapeutics [1–3]. To achieve sufﬁcient transfection
efﬁciency and functionality, several biological hurdles have to be over-
come. The plasmamembrane is the ﬁrst barrier, regulating the trafﬁck-
ing between the interior and exterior of the cell. Uptake of CPPs is
considered to start upon the interactionwith negatively charged plasma
membrane components, followed by internalization via different endo-
cytosis mechanisms. The internalization mostly takes place by clathrin-
dependent pathway [4,5], caveolin-dependent endocytosis [6,7] and via
macropinocytosis [8]. However, the exact mechanism may depend onansportan 10; PF, PepFect; ON,
DNA, plasmid DNA; SR-A, class
Cell Biology, 23 Riia Str, TartuCPP, cargo, used cell line or particular experimental conditions and fre-
quently different pathways may be utilized in parallel [4,9,10]. The
above mentioned features signiﬁcantly complicate the design and de-
velopment of new CPP-based pharmaceuticals. Although, some CPPs
can penetrate into cells independently from endocytosis and this path-
way has been suggested as the main cell entry mechanism for example
for CADY peptide [11] and for some arginine-rich peptides [9,12]; still if
CPPs are coupled to big macromolecules, endocytosis is considered as
the main uptake mechanism. Once inside the cells, the intracellular
fate and trafﬁcking of CPPs or CPP-cargo complexes is even less under-
stood. Entrapment of CPPs in endosomes is the next obstacle that limits
their access to intracellular targets.
Recently it was demonstrated that, in contrary to expected, the sec-
ond generation CPP, PepFect14 (PF14) forms negatively charged
nanocomplexes with splice correcting oligonucleotides (SCOs) [13],
which cannot associate with negatively charged proteoglycans for in-
duction of endocytosis. This ﬁnding implies that the cellular uptake of
PF14–SCO nanocomplexes has to be mediated by other types of recep-
tors. The plausible candidates, scavenger receptors, form a large super-
family, whose ﬁrst members were initially characterized by their
ability to bind and internalize modiﬁed low density lipoproteins.
However, they also associate with various other polyanionic ligands
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Moreover, scavenger receptors are known to facilitate the cellular up-
take of nucleic acids, like polyribonucleotides [15,16], dsRNA [17–19]
and polyvalent oligonucleotide-functionalized gold nanoparticles [20].
Further experiments with SR-A speciﬁc inhibitory ligands revealed
that the uptake of PF14–SCO complexes was indeed mediated by
these receptors, whose two subtypes SR-A3 and SR-A5 were present
in HeLa cells. The presence of inhibitory ligands abolished both the
binding of nanocomplexes at the plasma membrane and internaliza-
tion into cells [21]. Involvement of SR-As was further conﬁrmed by
ﬂuorescence microscopy, which demonstrated the colocalization of
nanocomplexes with both receptors on the plasma membrane as
well as after internalization inside the cells. Type A scavenger recep-
tors were recently shown to mediate the cellular uptake of PF14–
siRNA nanocomplexes [22], PepFect15 nanoparticles with SCO [23],
PF14–pDNA and NickFect nanoparticles with pDNA [24–26].
Therefore it is reasonable to assume that other gene delivery
vectors of PepFect and NickFect family also utilize SR-As to gain ac-
cess into cells.
Internalization of scavenger receptors may also occur via different
endocytosis pathways, such as clathrin-mediated endocytosis [14],
caveolin-dependent endocytosis [27,28] and macropinocytosis [29]. In
order to gain more insight into mechanism used by PF14–SCO
nanocomplexes, we ﬁrst aimed to pinpoint the particular endocytic
pathways responsible for the uptake and functionality of the
nanocomplexes as well as their intracellular trafﬁcking in reporter
HeLa pLuc705 cell line. Secondly, we aimed to obtain more detailed in-
formation about the interactions between the nanocomplexes and SR-
As by using transmission electron microscopy (TEM) to examine how
nanocomplexes interact with receptors and whether they can bind di-
rectly to receptors. We demonstrate that PF14–SCO nanocomplexes lo-
calize in very close proximity to both receptors, indicating that their
binding to receptors might be direct. Surprisingly, in cells that were
not treated with PF14–SCO nanocomplexes, SR-A3 and SR-A5 were
not exposed on the plasma membrane, whereas their intracellular con-
centration was high.
2. Materials and methods
2.1. Cells and materials
HeLa pLuc705 cells [30], kindly provided by Prof. R. Kole, were
grown in humidiﬁed atmosphere containing 5% CO2 at 37 °C in Iscove's
Modiﬁed Dulbecco's Medium (IMDM). Culture medium was supple-
mented with 10% fetal bovine serum (FBS), 100 IU/ml penicillin and
100 μg/ml streptomycin. PF14 was synthesized and puriﬁed as de-
scribed before [13]. Phosphorothioate 2′OMe splice correction oligonu-
cleotides with Cy5 labeling at the 5′ end were purchased from
Microsynth AG, Switzerland.
2.2. Formation of PF14–SCO complexes
To form complexes, Cy5 labeled SCO was mixed with PF14 (molar
ratio MR 1:5) in MQ-water in 1/10 of the ﬁnal treatment volume to
reach 0.2 μM and 1 μM concentration, respectively. Complexes were
formed for 30 min at room temperature.
2.3. Cellular uptake experiments
5 × 104 HeLa pLuc705 cells were seeded 2 days before the experi-
ment into 24-well plate. Cells were washed and pre-treated for
30min at 37 °C in serum containing IMDMwith 10 μMchlorpromazine,
50 μM nystatin or 1 mM amiloride (all from Sigma-Aldrich). Lipofecta-
mine 2000 (Invitrogen) was used as a control according to the
manufacturer's protocol. After that PF14–SCO complexes were added
and incubated for additional 4 h in serum containing media.Transfection medium was replaced with fresh media and incubated
for 20 h. Before the measurement, cells were washed twice with PBS
and lysed with 0.1% Triton X-100 in PBS buffer for 30 min at 4 °C. Lucif-
erase activitywasmeasured using Promega's luciferase assay systemon
GLOMAX 96 microplate luminometer (Promega, Sweden). For control
experiments, AF-594-conjugated transferrin, AF-555-labeled cholera
toxin B subunit (CtxB) and 70 kDa TAMRA-dextran (all from Molecular
Probes) were applied to cells at 20 μg/ml, 3 μg/ml, 0.25 mg/ml concen-
tration to test efﬁcacy of the inhibitors to block the uptake of respective
endocytic markers.
2.4. RNAi experiments
4 × 104 HeLa pLuc705 cells were seeded onto 12-well culture plate
24 h before siRNA transfection. siRNAs against SR-A3 and SR-A5
(Ambion, USA) were used as a mixture at ﬁnal concentration of 25 nM
of each and cav-1 siRNA (Santa Cruz Biotechnology, Heidelberg,
Germany) was used at ﬁnal concentration of 100 nM. Negative control
siRNA (Ambion, USA) was used at 50 nM or 100 nM concentration
and siRNAs were transfected into HeLa cells using Lipofectamine
RNAiMax (Life Technologies) according to the manufacturer's protocol.
48 h after the transfection cellswere treatedwith pre-formed PF14–SCO
nanocomplexes for 1 h, cells were then washed, lysed and analyzed
with Tecan Inﬁnite 200 M plate reader.
2.5. Localization of PF14–SCO complexes in relation to Golgi apparatus,
caveolin-1 and LAMP2
5 × 104 HeLa pLuc705 cells were seeded onto round glass coverslips
in 24-well plate 2 days before the experiment. Cells were washed and
incubated with complexes of 0.2 μM SCO and 1 μM PF14 for 30 min or
1 h at 37 °C in serum-free IMDM. Treated cells were then ﬁxed with
4% paraformaldehyde in PBS for 30 min, washed, permeabilized and
blocked with 5% non-fat dry milk solution in PBS for 30 min. Cells
were then treated with anti-TGN46 rabbit polyclonal antibody (1:100,
Abcam, UK) for 1 h at room temperature followed by incubation with
Alexa Fluor 488-conjugated anti-rabbit secondary antibody (1:500,
Invitrogen) for 30 min at RT. Colocalization of nanocomplexes with
caveolin-1 was analyzed by using anti-caveolin-1 rabbit polyclonal
antibody (1:100, BD Transduction Laboratories, Belgium) and Alexa
Fluor 488-conjugated goat-anti-rabbit secondary antibody (1:500,
Invitrogen) and LAMP2 was visualized with mouse polyclonal antibody
LAMP2 (1:100, H4B4, DSHB) andwith Alexa Fluor 488-conjugated goat-
anti-mouse secondary antibody (1:500, Invitrogen). After washing, the
coverslips were mounted with Fluoromount G (Electron Microscopy
Sciences, PA). Imageswere captured by Olympus FluoView FV1000 con-
focal laser scanning microscope using excitation at 488 nm (for TGN46,
cav-1 and LAMP2) and 633 nm (for SCO-Cy5) and processed with
Adobe Photoshop CS6.
2.6. Co-localization of PF14–SCO complexes with Golgi apparatus,
endoplasmic reticulum, dextran and CellMask in live cells
7 × 104 HeLa pLuc705 cells were seeded onto 8-well chambered
coverglasses (Lab-Tek, Nalge Nunc International, NY) 2 days prior to ex-
periment. At 80% of conﬂuence, cells were washed and incubated in
serum-free media for 2 h. After that cells were pre-incubated with
Golgi marker 0.5 μM BODIPY-TR-C5 ceramide (Molecular Probes, UK)
in serum-free media for 30 min on ice. Cells were washed again and in-
cubated with PF14–SCO complexes in serum-free media for an addi-
tional 30 min or 1 h at 37 °C. To visualize the localization of
complexes in relation to endoplasmic reticulum, cells were incubated
with PF14–SCO complexes and 0.2 μM Blue–White DPX (Molecular
Probes, UK) in serum-free media for 30 min or 1 h at 37 °C. Images
were captured by Olympus FluoView FV1000 confocal laser scanning
microscope using excitation at 590 nm (for Golgi marker), 380 nm
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Adobe Photoshop CS6. Colocalization with the respective endocytosis
markers was calculated by counting all internalized PF14–SCO
nanocomplexes and the number of complexes that colocalized with a
particular marker in 105 cells. Colocalization was calculated as the per-
centage of all internalized nanocomplexes.
To examine the colocalization between 70 kDa TAMRA-dextran
(Invitrogen) and nanocomplexes, cells were incubated simultaneously
with pre-formed PF14–SCO nanocomplexes and 0.25 mg/ml dextran
for 30 min in serum-free IMDM medium at 37 °C. Cells were then
washed and examined with confocal laser scanning microscope
using excitation at 559 nm (for TAMRA-dextran) and 633 nm
(for nanocomplexes). To assess the localization of PF14–SCO
nanocomplexes relative to the plasma membrane, cells were ﬁrst incu-
bated with PF14–SCO complexes in serum-free IMDM for 30 min or
1 h. Cells were then washed and incubated with CellMask Green plasma
membrane stain (1:1000, Invitrogen) for 10 min at 37 °C, washed andFig. 1. Cellular uptake of PF14–SCO complexes intoHeLa cells. (A)HeLa pLuc705 cellswerepretr
30min before the addition of complexes of 0.2 μMSCOwith 1 μMPF14. Luciferase activitywasm
SCO complexeswithout the presence of inhibitors (PF14). Error bars representmean± SEM. (B
48 h after siRNA transfection, cells were incubatedwith PF14–SCO-Cy5 complexes for 1 h and C
SEM of ≥3 experiments done in duplicate. **P b 0.01, Student's t-test. (C) HeLa pLuc705 cells w
caveolin was visualized using caveolin-1 primary antibody (1:100) and AF488-conjugated se
TAMRA-dextran, HeLa pLuc705 cells were co-incubated with PF14–SCO-Cy5 complexes and 0
arrowheads. Scale bar 10 μm.imageswere capturedwith confocal laser scanningmicroscope using ex-
citation at 488 nm (for CellMask) and 633 nm (for nanocomplexes) and
processed with Adobe Photoshop CS6.2.7. Visualization of PF14–SCO nanocomplexes in relation to vesicles of
endo-lysosomal pathway in live cells
HeLa pLuc705 were grown on chambered coverglasses as described
above. At 80% conﬂuence, cells were washed and incubated with PF14–
SCO complexes or “naked” 1 μM SCO-Cy5 for 1 h, 2 h and 4 h in serum-
free medium at 37 °C. 2 h prior to desired time point, cells were washed
twice with PBS and incubated with 2 μM LysoSensor-DND-189
(Molecular Probes, UK) in serum-free media to distribute LysoSensor
along endo-lysosomal pathway. Images were captured by Olympus
FluoView FV1000 confocal laser scanning microscope using excitation
at 458 nm (for LysoSensor) processed with Adobe Photoshop CS6.eatedwith chlorpromazine (Cpr, 10 μM), nystatin (Ny, 50 μM)or amiloride (Am, 1mM) for
easured 24h after the transfection. Results are presented as percentage of activity of PF14–
) HeLa pLuc705 cells were treatedwith scrambled siRNA (0.1 μM)or cav-1 siRNA (0.1 μM).
y5 signal wasmeasuredwith Tecan Inﬁnite 200M plate reader. Values represent means±
ere treated with nanocomplexes of 1 μM PF14 and 0.2 μM SCO-Cy5 for 30 min, ﬁxed and
condary antibody (1:500). To examine the colocalization of nanocomplexes with 70 kDa
.25 mg/ml dextran for 30 min. Colocalization is visible as yellow color and is indicated by
Fig. 2. Localization of PF14–SCO complexes in HeLa cells in relation to Golgi apparatus and endoplasmic reticulum. (A, B) HeLa pLuc705 cells were incubatedwith complexes of 1 μMPF14
with 0.2 μMSCO-Cy5 (red) for 30min (A) or 60min (B). Cells were then ﬁxed and the Golgi regionwas visualized by antibody staining against the trans-Golgi network (TGN) (green). (C,
D) HeLa pLuc705 cells were pre-treated with BODIPY TR-ceramide (red) for 30 min on the ice before the addition of Cy5 labeled SCO complexes (green pseudo color) with PF14 and
incubated for an additional 30 min (C) or 60 min (D). (E–F) HeLa pLuc705 cells were pre-treated with ER marker Blue–White DPX (red pseudo color) for 30 min on the ice before the
addition of Cy5-labeled SCO complexes (green pseudo color) with PF14 and incubated for an additional 30 min (E) or 60 min (F). Negligible fraction of the complexes was trafﬁcked to
Golgi apparatus after 30 min (A, C, insets) and 60 min (B, D, insets). No colocalization was found with ER and complexes neither after 30 min (E) nor after 60 min (F) incubation time.
Scale bar 10 μm.
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SCOswere labeledwithNanogold™ (Nanoprobes, Yaphank, NY) and
specimenswere prepared for TEM as described previously [31]. To form
complexes, nanogold-labeled SCO was mixed with PF14 (MR 1:5) in
MQ-water in 1/10 of the ﬁnal treatment volume to reach 0.2 μM and
1 μM concentration, respectively. Complexes were formed for 30 min
at room temperature.
Biotinylated SCO (0.2 μM) (Microsynth AG, Switzerland) was ﬁrst
associated with 10 nm NA–Au conjugate [6] (in 3:1 molecular ratio)
for 30 min at 37 °C, followed by complexation with PF14 (1 μM) in
Milli-Q water in 1/10 of the ﬁnal treatment volume.2.9. Electron microscopy and pre-embedding immunolabeling
HeLa pLuc705 cells were seeded onto round glass coverslips in
35 mm cell culture dishes and grown to 80–90% conﬂuence. Cells
were incubated with PF14–SCO nanocomplexes for 1 h at 37 °C. After
that, cells were washed and ﬁxed for immunoelectron microscopy
with PLP ﬁxative [32] at room temperature for 2 h. Cells were perme-
abilized with 0.01% saponin in 0.1 M sodium phosphate buffer
(pH 7.4) supplemented with 0.01% BSA for 8 min. Afterpermeabilization cells were incubated with goat anti-SCARA3 (G-16,
1:50; Santa Cruz Biotechnology, Heidelberg, Germany) or rabbit anti-
SCARA5 (HPA024661, 1:50; Sigma-Aldrich, Taufkirchen, Germany)
polyclonal antibodies followed by the treatment with 6 nm or 10 nm
gold tag labeled Protein-G (1:40) (Aurion Immuno Gold Reagents & Ac-
cessories, Netherlands) for an additional hour. After postﬁxation with
1% osmium tetroxide in 0.1 M sodium cacodylate buffer, samples were
dehydrated and embedded in TAAB 812 epoxy resin (TAAB Laboratories
Equipment Ltd., UK). Ultra-thin sectionswere cut in parallel with cover-
slips, poststained with uranyl acetate and lead citrate and examined
with FEI Tecnai G2 Spirit transmission electron microscope at 120 kV.
Electron microphotos were analyzed and processed with Adobe
Photoshop CS6. Quantiﬁcations were made by counting 50 PF14–
pDNAparticles or receptor complexes from3 independent experiments.3. Results
3.1. PF14–SCO complexes induce splice correction after internalization via
macropinocytosis and caveolin-mediated endocytosis
Previously, we have shown that PF14–SCO complexes are recog-
nized and endocytosed by class A scavenger receptors [21] but the
Fig. 3. Localization of PF14–SCO nanocomplexes in cells in relation to acidic endosomes and lysosomes. HeLa pLuc705 cells were incubated with 1 μM PF14 complexed with 0.2 μM Cy5-
labeled SCO (A–C) or with “naked” 1 μM Cy5-labeled SCO (red color) (D–F) for 1 h (A, D), 2 h (B, E) and 4 h (C, F) and 2 μM LysoSensor DND-198 (green) to visualize the trafﬁcking of
complexes or “naked” SCO in endo-lysosomal pathway. Colocalization between PF14–SCO complexes or “naked SCO” (red) and LysoSensor-positive vesicles (green) is visible as yellow
signal and indicated by arrowheads. Scale bar 10 μm.
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tion modes used by SR-As are responsible for the biological activity in
PF14-mediated SCO delivery, we used pharmacological inhibitors to
block the relevant endocytosis pathways. HeLa pLuc705 cells were
treated with a battery of commonly used inhibitors for 30 min prior
addition of PF14–SCO nanocomplexes. Cells were treated with chlor-
promazine to suppress clathrin-dependent endocytosis [33], with nys-
tatin to inhibit caveolin-dependent route [34] and amiloride to
interferewithmacropinocytosis [35]. The efﬁcacy of the inhibitors to in-
hibit the uptake of the respective endocytic markers, transferrin,CtxB
and dextran, was assessed in parallel, and all used inhibitors suppressed
the internalization of markers of endocytosis (Fig. S1). In the absence of
inhibitors PF14–SCO complexes induced more than a 100-fold increase
in luciferase expression due to the splice-switching activity. The most
potent inhibitor was amiloride that reduced SCO mediated splice cor-
rection up to 80% (Fig. 1A), suggesting that PF14–SCO complexes are
mainly internalized viamacropinocytosis. To better visualize the impor-
tance of macropinocytosis, we co-incubated cells with nanocomplexes
and ﬂuid-phase marker 70 kDa dextran and analyzed their location in
HeLa cells. Colocalization studies showed that majority of cell surface
bound PF14–SCO complexes colocalized with dextran (Fig. 1C, lower
panels and insets 1–2). However, after 30 min of incubation some of
the complexes had also entered the cells, where they were located in
punctuate structures together with dextran. These results corroborate
the involvement of macropinocytosis in endosomal uptake of PF14–
SCO nanocomplexes. Nystatin reduced the splice correction about 30%,
but chlorpromazine, an inhibitor of clathrin-mediated endocytosis had
no effect on the uptake of the nanocomplexes (Fig. 1A). Immunoﬂuores-
cence analysis revealed that a fraction of PF14–SCO complexes on the
plasma membrane colocalized with caveolin-1 within 30 min (Fig. 1C
upper panels and insets 1–2 arrowheads point to colocalization). This
is in good concordance with results with pharmacological inhibitors ofendocytosis that pointed to aminor role of caveolin-dependent endocy-
tosis in the uptake of PF14–SCO complexes. To further conﬁrm the role
of caveolin, we depleted caveolin-1 by using siRNA (Fig. 1B). Knock-
down of caveolin-1 in HeLa cells reduced the uptake of PF14–SCO
nanocomplexes by about 40% compared to control cells not treated
with siRNA or cells treatedwith scrambled siRNA (Fig. 1B). These results
suggest that SR-A3 and SR-A5 receptors induce the cellular uptake of
PF14–SCO nanocomplexes mainly by triggering macropinocytosis and
caveolin-dependent endocytosis, whereas clathrin-dependent internal-
ization route does not seem to contribute to the uptake in these reporter
cells.3.2. PF14–SCO nanocomplexes are not targeted to endoplasmic reticulum
and Golgi apparatus
SR-As are known to translocate from the plasma membrane into dif-
ferent organelles, and in order to acquire information about the fate of
PF14–SCO nanocomplexes after internalization, we examined their desti-
nation in cells. Material that enters cells via caveolin-dependent route, in-
cluding SR-As, can be targeted to Golgi apparatus and endoplasmic
reticulum (ER) [36]. After 30 min of incubation time, nanocomplexes
were mainly found in vesicles near the plasma membrane (Fig. S2), and
a smaller fraction of these were routed into vesicles in the perinuclear re-
gion of the cell (Fig. S2). However, only about 1.9% of the internalized
complexes showed colocalization with Golgi network, which was visual-
ized either by antibody staining against the trans-Golgi network (TGN)
(Fig. 2A and insets 1–2 arrowheads point to colocalization) or with ﬂuo-
rescently tagged ceramide (Fig. 2C and insets 1–2) after 30 min incuba-
tion. Later, after 1 h, more complexes had shifted away from the plasma
membrane towards the cell nucleus (Fig. S2), but their colocalization
with Golgi was even reduced to 1.2% (Fig. 2B, D and insets 1–2).
3210 C. Juks et al. / Biochimica et Biophysica Acta 1848 (2015) 3205–3216
3211C. Juks et al. / Biochimica et Biophysica Acta 1848 (2015) 3205–3216Mapping of the PF14–SCO intracellular localization in relation to en-
doplasmic reticulum revealed the complete lack of colocalization both
after 30min and 1 h (Fig. 2E, F and insets). The absence of colocalization
demonstrates that despite being endocytosed by caveolin-dependent
route and macropinocytosis, PF14–SCO nanocomplexes are not traf-
ﬁcked to ER or Golgi apparatus by SR-As.
3.3. PF14–SCO complexes avoid the endo-lysosomal pathway inside the
cells
Since the colocalization with ER and Golgi apparatus was negligible,
we next examined the targeting of PF14–SCO complexes to endo-
lysosomal pathway, using LysoSensor reporter to estimate the pH of
vesicles that contained nanocomplexes. LysoSensor is internalized into
cells via endocytosis and its ﬂuorescence intensity inversely correlates
with the pH value: more acidic vesicles emit higher ﬂuorescence signal
than vesicles with slight acidity. After incubation for 1 h, themajority of
the PF14–SCO complexes were localized at the cell periphery in non-
acidic vesicles that resembled early endosomes (Figs. 3A, S3). Later,
the complexes reached deeper inside of the cells and also the number
of vesicles that contained complexes increased, but still no signiﬁcant
colocalization with LysoSensor was observed (Figs. 3B, S3), suggesting
that evenwithin 2 h complexes residemainly in neutral or slightly acid-
ic vesicles. After 4 h the majority of complexes were still found in non-
acidic vesicles (Fig. 3C) and only few of them had reached low-pH ves-
icles (Figs. 3C and insets 1–2; S3). Experimentswith LysoSensor demon-
strate that a very small fraction of PF14–SCO complexes was targeted to
degradation within 4 h, which is in a good agreement with the data
from experiment with pharmacological inhibitors of endocytosis. PF14
as a derivative of TP10 might interfere with the acidiﬁcation of
endocytic vesicles [37,38]; therefore we also assessed targeting of
nanocomplexes to LAMP2-positive late endosomes/lysosomes as a
function of incubation time (Fig. S4). However, we did not observe
colocalization of nanocomplexes with LAMP2 after 1 h of incubation
and only very rare colocalization with lysosomes was found after 2–
4 h of incubation (Fig. S4).
Since the intracellular trafﬁcking of nanocomplexes could be guided
by both the nanocomplexes and receptors, we also analyzed the intra-
cellular localization of “naked” SCO. After 1 h of incubation the
“naked” SCO had distributed in HeLa cells in rather analogous manner
with its nanocomplexes with PF14, and it was mainly found in vesicles
close to the plasma membrane. These vesicles were mostly non-acidic
and did not reveal LysoSensor signal (Figs. 3D, S3). However, at later
time points the character of vesicles entrapping the complexes and
free nucleic acid started to differ. After 2 h, the major fraction of
“naked” SCO had reached the LysoSensor-positive vesicles with the
dropped pH (Figs. 3E and insets 1–2; S3). In time, the intensity of the
LysoSensor signal in vesicles with SCO increased evenmore, and in par-
allel, the number of SCO-containing acidic vesicles increased. After 4 h,
almost all the SCOs in cells were sequestered into lysosomes (Figs. 3F
and insets 1–2; S3). This was further conﬁrmed by analyzing
colocalization with LAMP2, which showed a major colocalization be-
tween the LAMP2-positive vesicles and SCO after 4 h of incubation
(Fig. S4). These results suggest that although “naked” oligonucleotide
at high concentration could associate with SR-A3 [21] and enter cells,
after internalization they are targeted to lysosomes for degradation. It
seems reasonable to speculate that PF14 packs SCO into particles for
better recognition by SR-As, helps to interfere with the endosomal acid-
iﬁcation and promotes endosomal escape to ensure the functionality of
the cargo.Fig. 4. Escape of PF14–SCO nanocomplexes from endosomes and translocation into nucleus. He
beled with 1.4 nm gold tag) at 37 °C for 1 h (A) and 4 h (B, C, D) and their localization was ana
cubation and endosomal escape (pointedwith arrows) (A). Localization of nanocomplexes insid
A signiﬁcant fraction of the complexes were detected in the cytosol (B and C insets, indicated w
inset). Scale bar 500 nm, n-nucleus. (E) Shows the number of PF14–SCO nanocomplexeswhich a3.4. Escape of PF14–SCO nanocomplexes from endosomes
Since PF14–SCO nanocomplexes were not targeted to acidic vesicles
and potently corrected splicing of luciferase mRNA, we next examined
their intracellular trafﬁcking by TEM.We analyzedwhen the endosomal
escape starts,which type of vesicles preferentially leak, andwhether the
SCO could reach the nucleus.
Although PF14–SCO nanocomplexes have internalized into cells al-
ready within 30 min after the transfection, the number of complexes
in cells was substantially higher after 1 h and it continued increasing.
The majority of complexes localized in cells in large vesicles (about
300 nm in diameter) that resembled multivesicular bodies, but were
still rather “electron-light”. Inside vesicles, the nanocomplexes typically
localized close to the vesicle's membranes on the electron dense back-
ground. In some loci the nanocomplexes were in contact with the
endosomal membrane and induced breaches in membranes (Fig. 4A
inset, membrane breaches are indicated with arrowheads). Starting
from 1 h incubation, we detected endosomal vesicles with fragmentary
membrane and at the same time nanocomplexes were found escaping
from endosomes and distributing to the cytosol (Fig. 4A). Although
the escape of nanocomplexes from endosomes started from 1 h after
uptake, in rare cases we detected SCO in cytosol already in 30 min.
Later, 4 h after transfection, the nanocomplexes had shifted to the
perinuclear region and higher amount of complexes was found in the
cytosol (Fig. 4B and insets 1–2 arrowheads indicate to complexes; C).
To estimate the number of nanocomplexes that are entrapped into
endosomes and the number of which have been escaped to the cytosol,
over 2000 particles from 70 TEM images were counted. The fraction of
nanocomplexes that had escaped form endosomes to the cytosol over
4 h of incubation time was about 8% (Fig. 4E). In cytosol, the PF14–
SCO complexes were detectable as small clusters, containing a few
SCO molecules, whereas the nanocomplexes on the plasma membrane
or in the vesicles were substantially bigger containing tens of SCO mol-
ecules. By this time point a few SCOmolecules had also translocated into
nucleus (Fig. 4D, inset). Although the number of nanocomplexes detect-
ed in the nucleus after 4 h-incubationwas very low, this result is in good
concordance with earlier results. Ezzat et al. examined the kinetics of
PF14–SCOmediated splice-correction and found that about 60% ofmax-
imal splice correction was obtained already 8 h after the transfection
[13]. In contrary to nanocomplexes “naked” SCO without the peptide
did not form such clusters and they are rather associated at the plasma
membrane as individual particles (Fig. S5). Despite of having no trans-
port molecule, a small amount of “naked” SCO is still internalized with
low efﬁciency into cells via endocytosis and these molecules could be
found in endosomal vesicles (Fig. S5). However, the amount of
“naked” SCO detected by TEM on the plasmamembrane and in the ves-
icles in cytoplasm very small compared to its complexes with the pep-
tide and they were much rarer than we observed by confocal
microscopy (Figs. 3 and S4). This implicates that the confocal microsco-
py could overestimate the association of “naked” SCO with cells, or the
less tightly bound oligonucleotides aremore easily removed upon spec-
imen preparation by TEM. However, after 4 h of incubation still “naked”
SCO was detected in vesicles, which had increased size and contained
numerous intraluminal vesicles (Fig. S5). Moreover, we never detected
“naked” SCO outside endosomal vesicles in cell cytoplasm even after 4 h.
3.5. PF14–SCO complexes can associate with SR-A receptors
Using ﬂuorescencemicroscopywe have shown that PF14–SCO com-
plexes associatewith scavenger receptors on theplasmamembrane andLa pLuc705 cells were incubated with nanocomplexes of 1 μM PF14 with 0.2 μM SCO (la-
lyzed by TEM. Localization of PF14–SCO nanocomplexes inside the vesicles after 1 h of in-
e the cells inmultivesicular bodies (B) and in the perinuclear region (C) after 4 h of uptake.
ith arrowheads) and some of them had reached into the nucleus upon 4 h-incubation (D,
re entrapped into the endosomes and the amount of that have been escaped to the cytosol.
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order to gain amore detailed insight into how these nanoparticles inter-
act with receptors and whether these complexes can directly associate
with SR-Asweused TEM. Tobetter distinguish and visualize the interac-
tions between SR-A receptors and nanoparticles by TEM,we labeled the
PF14–SCOnanoparticleswith 10 nmcolloidal gold and SR-A3 and SR-A5
receptors were visualized by using respective primary antibodies and
secondary antibodies that carried a 6 nm gold tag.
Binding of PF14–SCO complexes to the plasma membrane induced
their association into small clusters, which typically contained 3–10
gold particles (Fig. 5A). These clusters were often found on the plasma
membrane rufﬂes (Fig. 5A), which further support the involvement of
macropinocytosis in the uptake of PF14-nanocomplexes. After 1 h-incu-
bation, the complexes had entered the cells and localized mainly in
multivesicular bodies, where they still retained association into smaller
cluster like on the plasma membrane (Fig. 5B). However, at this time
point we could detect only negligible amount of such complexes in
the cytosol out of vesicles. Next we analyzed the localization of
nanocomplexes in relation to SR-A receptors. After 1 h of incubation
time we could observe both type 3 and 5 of SR-A receptors in very
close proximity to complexes on the plasma membrane (Fig. 5C, D, ar-
rowheads point to receptors), and also induction of endosomal invagi-
nations. Nanocomplexes and receptors were located very closely in
induced invaginations (Fig. 5C inset, arrowhead indicate to receptor),
indicating that PF14–SCO complexes associatewith scavenger receptors
which assist their internalization into cells. Only a few receptors are re-
quired for efﬁcient internalization and already within 1 h of incubation
time, nanocomplexes and SR-A receptors were found in endocytic ves-
icles (Fig. 5E, F). PF14–SCO complexes are preferentially concentrated
at the limiting membrane of endocytic vesicle membrane, where we
typically also found a few receptors (Fig. 5E and F insets, arrowheads in-
dicate to receptors). To further support the involvement of scavenger
receptors in the uptake of PF14-nanocomplexes we next knocked-
down both receptors in HeLa cells. Treatment of cells with siRNAs
against SR-A3 and SR-A5 (25 nM of each) reduced the internalization
of PF14–SCO complexes about 50%, whereas treatment of cells with
scrambled siRNA had no effect on the uptake process of nanocomplexes
(Fig. 5G). These results further corroborate that scavenger receptors are
needed for efﬁcient uptake of PF14-nanocomplexes.
3.6. SR-As are not exposed on the plasma membrane of control cells
The colocalization of PF14–nucleic acid complexes with SR-A3/5 on
the plasma membrane and rufﬂes/ﬁlopodia impelled us to map the lo-
calization of these receptors inHeLa pLuc705 cells in detail. Surprisingly,
we could not detect receptors on the surface of control cells that were
not treated with PF14–nucleic acid nanocomplexes (Fig. 6A, B). This
ﬁnding was also supported by confocal microscopy, where in control
cells, SR-A3 and SR-A5 receptors were not on the plasma membrane;
however, treatment with PF14–SCO complexes induced translocation
of both receptors to the cell surface (Fig. S6). Still, receptors were easily
detectable inside the cells in substantial amounts. Both, SR-A3 and SR-
A5 receptors localized in small vesicles very close to the plasma mem-
brane and within more central membranous structures as revealed by
TEM analysis (Fig. 6A, B). Remarkably, immunological detection typical-
ly revealed the presence of clusters that contain 2–5 gold particles con-
sistentwith the trimeric architecture of these receptors. However,when
cells were incubated with complexes of PF14 and SCO or pDNA, SR-As
were translocated from the cytoplasm to the plasma membraneFig. 5. Colocalization of PF14–SCO nanocomplexes with SR-A receptors in cells. HeLa pLuc705 c
10 nm colloidal gold particle for 1 h at 37 °C. SR-A3 (C, E) and SR-A5 (D, F) receptors were visu
gold particles. Interactions of PF14–SCO complexes with the plasma membrane (A) and locali
insets) and SR-A5 (D, F, insets) on the plasma membrane and in the cells. Arrowheads point t
uptake of complexes by siRNA-treated cells. HeLa cells treatedwith scrambled siRNA (50 nM) o
of PF14 (1 μM) and SCO-Cy5 (0.2 μM) for 1 h and the ﬂuorescence of cells was quantiﬁed by Te
duplicate. ***P b 0.001, Student's t-test.(Fig. 6C, D) as evidenced by both confocalmicroscopy and TEM analysis.
TEM images revealed that after induced translocation to the plasma
membrane, SR-As can form clusters of 5–10 receptor monomers
(Fig. 6C, D). After exposure of HeLa cells to PF14–nucleic acid
nanocomplexes, SR-A3 and SR-A5 were often detected on the plasma
membrane on ﬁlopodia/rufﬂes, the structures that were absent in con-
trol cells. It is likely that the ﬁrst interaction of PF14–nucleic acid
nanocomplexes with scavenger receptors takes place (at least partially)
on the membrane protrusions and later complexes are transported to-
wards the cell body for endocytosis.
4. Discussion
CPPs have turned into powerful vehicles for the delivery of various
cargos into cells and they have an immense potential to deliver different
bioactivemolecules both in vitro and in vivo. Despite being under inves-
tigation for more than 20 years, their mechanisms are not fully under-
stood and several studies have shown controversial results. Recently,
we have shown that some CPP-based delivery systems of nucleic acid
can act using speciﬁc receptors on the plasma membrane to induce en-
docytosis [21]. Namely, class A scavenger receptor subtypes SR-A3 and
SR-A5 were necessary for PepFects and NickFects mediated oligonucle-
otide delivery [21–26]. Scavenger receptors are known to bind a wide
variety of negatively charged macromolecules [39] and to induce their
internalization using all endocytic pathways characterized so far [14].
To gain better insight into SR-As as targets for the CPP based nucleic
acid delivery, we aimed to study further the uptakemechanisms and in-
tracellular trafﬁcking of PF14–SCO complexes in HeLa pLuc705 cells.We
also sought formore detailed information howPF14–SCOcomplexes as-
sociate with SR-As and whether the interaction is direct.
To elucidate which endocytic routes are responsible for the activity
of PF14–SCO complexes, we used pharmacological inhibitors.
Amiloride, an inhibitor of macropinocytosis, reduced the splice-
correcting effect of PF14–SCO nanocomplexes at the greatest extent.
Macropinocytosis has previously been demonstrated as the main
entry route for arginine-rich CPPs such as nona-arginine and Tat-
peptide [8,40], and also for NickFect mediated cargo delivery [24]. Inhi-
bition of caveolin-mediated endocytosis with nystatin or with caveolin-
1 speciﬁc siRNA reduced the activity of nanocomplexes about 30% and
40% respectively, suggesting that at least two different endocytic path-
ways are active in parallel. On the other hand, inhibition of clathrin-
mediated endocytosis, that has been considered to be the main uptake
route for receptor dependent endocytosis, had no inﬂuence on the bio-
logical activity of PF14–SCO complexes. Our results seem to contradict
recently published data, where Bitsikas et al. have proposed that 95%
of the plasma membrane proteins are internalized into cells via rapid
clathrin-dependent endocytosis [41]. Biotinylated cell surface proteins,
examined in this paper, are probably taken up via constitutive way
within very few seconds, as they just follow the uptake without any
stimulation. However, in a case of CPP-nanoparticle uptake, endocytosis
is rather a stimulated process occurring after binding of complexes to
the plasma membrane and translocation of receptors to cell surface.
The involvement of caveolae-mediated endocytosis has been reported
in the cellular uptake of TP10-cargo delivery, the parent peptide of
PepFects, as well as in the uptake of PF14–pDNA and NickFect-cargo
complexes into HeLa cells via SR-As [24,26]. Caveolae-dependent scav-
enger receptor class A mediated endocytosis was recently found to be
the major uptake route for spherical nucleic acids [28]. The caveolar
pathway is also responsible for the cellular uptake and biologicalells were incubated with preformed complexes of PF14 and biotinylated-SCO tagged with
alized with anti-Scara3 and anti-Scara5 primary antibodies and Protein-G coupled to 6 nm
zation inside the cells (B). Localization of PF14–SCO complexes in relation to SR-A3 (C, E,
o receptors that localize in close proximity to nanocomplexes. Scale bar 500 nm. (G) The
r speciﬁc siRNAs against SR-A3 and SR-A5 (25 nMof each)were incubatedwith complexes
can Inﬁnite 200 M plate reader. Values represent means± SEM of ≥3 experiments done in
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Fig. 6. SR-A receptors are targeted to the cell surface upon treatment with PF14–SCO nanocomplexes. HeLa pLuc705 cells were incubated with PF14 nanocomplexes with SCO for 1 h at
37 °C. SR-A receptors were visualizedwith anti-Scara3 and anti-Scara5 primary antibodies and 10 nmgold tag labeled Protein-G. In control cells receptors localized only inside cells (A, B).
Incubation of HeLa cells with PF14–SCO nanocomplexes translocated both receptors to the plasma membrane (C, D).
3214 C. Juks et al. / Biochimica et Biophysica Acta 1848 (2015) 3205–3216activity of conjugates of splice switching oligonucleotides with cell pen-
etrating peptide in mdx skeletal muscle cells and murine model of
Duchenne Muscular Dystrophy [42].
After budding from the plasma membrane, CPP-cargo complexes re-
main entrapped in endocytic vesicles. Since the exact uptakemechanism
used by CPPs may depend on the cargo [9,43,44] and the uptake route
determines further intracellular localization, and the fate of endocytosed
material, we next followed the intracellular trafﬁcking of the complexes
after the internalization. Papers, published in the ﬁeld of scavenger re-
ceptors have mainly focused on their role in different cellular processes,
among which some papers have also established the uptake route, but
exact cellular trafﬁcking is not well studied so far. In general, binding
of ligand to scavenger receptors induces internalization via endocytic
pathway(s) and accumulation into endosomes, where the ligand is dis-
sociated from receptor in acidic conditions of the endosomes and is sub-
sequently transported to lysosomes for degradation. Once inside the
cells, receptor–ligand complexes are also shown to trigger several intra-
cellular signaling pathways [17,19], however, less discussed is the fate of
internalized receptors. One possibility is that receptors are recycled back
to the cell surface, where they can bind and internalize next ligands, or
they can undergo lysosomal degradation, and thereby control their ac-
tivity in the cells [14,45].
Several studies have demonstrated that the material endocytosed
via caveolin-mediated pathway could be directed to the endoplasmic
reticulum and Golgi apparatus [36,46]. To examine, whether PF14–
SCO nanocomplexes are also targeted to these organelles, we used con-
focal microscopy and analyzed the colocalization with ER and Golgi in
HeLa cells. However, we did not detect any colocalization of PF14–SCO
nanocomplexes and ER, and observed only a negligible colocalization
with Golgi apparatus shortly after the internalization. At later time
points, the number of the nanocomplexes localizing to Golgi decreased
and after 1 h of incubation only about 1% of the complexes were found
in Golgi complex. Also our TEM data did not show the accumulation of
PF14–SCOnanocomplexes to theGolgi apparatus. Our results contradictthe fact that the contents of the caveosomes are targeted to the ER or
Golgi apparatus and allowed us to suggest that some other trafﬁcking
routes were utilized. Analogous localization pattern was described ear-
lier in the case of TP10-mediated protein delivery via caveolin-
dependent endocytosis, where only a negligible fraction of the cargo
was found to colocalize with Golgi apparatus [32].
Another major intracellular trafﬁcking route is the endo-lysosomal
pathway. During the endosome maturation the internalized material
is transported to gradually acidifying vesicles that ﬁnallymature to lyso-
somes, where the degradation of endocytosed material occurs.
Endosomal entrapment is believed to be the main obstacle that limits
the application of bioactive nanocomplexes, whose target is in the cyto-
plasm or the nucleus. To clarify whether PF14–SCO complexes are
targeted along the endo-lysosomal pathway,we used LysoSensor to dis-
tinguish the acidic vesicles among endocytic organelles. After transfec-
tion, we observed punctuate distribution of the complexes in the
cytosol, but no signiﬁcant colocalization with LysoSensor was detected.
In time the number of the complexes that had entered the cells in-
creased, but the majority of these avoided transfer into endo-
lysosomal pathway, even after 4 h. Thus, it can be suggested that the
nanocomplexes are located in rather non-acidic or moderately acidic
vesicles, which is in good agreement with the results of uptake experi-
ments, which demonstrated the prevalence of caveolin-dependent en-
docytosis and macropinocytosis in PF14 mediated SCO delivery.
Caveosomes, unlike other endocytic organelles, are considered to pos-
sess a non-acidic pH [46]. We speculate that the nature of caveosomes
and slower maturation rate than observed for clathrin-mediated endo-
cytosis grant the complexes anopportunity to escape into cytosol before
the endosomal acidiﬁcation and fusion with degradative lysosomes
occur. Our results also correlate with earlier studies, where transportan
andTP10were found to be targeted to vesicles,whose pHhadonly slightly
decreased [37]. Very recent experiments with lipid-siRNA nanoparticles
showed that endosomal escape only occurred at the speciﬁc stage
of endosomal trafﬁcking [47]. siRNA release was found to occur from
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endosomal vesicles. Some studies also demonstrated that efﬁcient
endosomal escape may occur from macropinosomes as these vesicles are
considered to be leakier thanother endosomal compartments [48]. Second
generation CPPs, like PepFects, are able to promote efﬁcient endosomal
leakage due to their modiﬁcations, that leads to the liberation of the
nucleic acid cargo from entrapment and to high transfection efﬁciencies
[13,49]. Spherical nucleic acids (SNAs), which are also taken up by cells
via SR-As and caveolae-mediated pathway, are shown to localize into
early endosomes within 1–2 h of incubation time, in analogy with our
results [28]. However, in time these vesicles mature into late endosomes,
where SNAs stay for at least 24 h, as demonstrated by the authors [50].
Still, SNAs did not follow the classical endo-lysosomal pathway, and
showed no colocalization with lysosomal marker LAMP1 or maturation
into lysosomes [50]. These ﬁndings also support the idea, that CPPs are
required for promoting endosomal escape and biological activity of cargo
molecules. Furthermore, SNAs did not reveal colocalization or targeting
to trans-Golgi network [50], exactly aswe showed for PF14–SCOnanopar-
ticles. It seems that SNAs and CPP-SCO nanocomplexes share similar
uptake routes and cellular trafﬁcking, at least at early time points.
Surprisingly we found that “naked” oligonucleotides at higher con-
centration (1 μM) were also able to internalize into cells, but already
after 2 h the majority of SCO in cells was found in LysoSensor positive
vesicles. Later, the amount of SCO entrapped into endosomes in-
creased and these vesicles becamemore acidic, suggesting that the ol-
igonucleotides were mainly targeted to lysosomes. Although several
reports have demonstrated the ability of “naked” oligonucleotides to
promote the biological activity [51,52], it perhaps occurs at lower
levels, at high concentration and preferentially with extensively
modiﬁed oligonucleotides.
Next we aimed to study how PF14–SCO nanocomplexes interact with
receptors andwhether these complexes can bind directly to SR-As. Previ-
ously, we demonstrated by ﬂuorescence microscopy that the
nanocomplexes colocalize with SR-As on the cell surface, and also inside
the cells. In order to gain a more detailed insight, we used TEM utilizing
differential labeling strategy for distinguishing the SR-As and the
nanocomplexes. We found that PF14–SCO nanocomplexes reside in the
close proximity to receptors on the plasma membrane, suggesting that
the nanocomplexes could directly associate with receptors and promote
endocytosis. After internalization, SR-As andnanocomplexesweremainly
entrapped in the endocytic vesicles, retaining colocalization. Both SR-A3
and SR-A5 receptors were localized at the boundaries of the complexes
close to the membrane of endosomal vesicles. Interestingly, treatment
of cells with PF14–SCO nanocomplexes induced the formation of plasma
membrane protrusions; however, these protrusions did not form in the
untreated control cells. Induction of ﬁlopodia and rufﬂes by the
nanocomplexes suggests the triggering of macropinocytosis; and indeed
it was found to play a signiﬁcant role in the biological activity of PF14–
SCO complexes. Our results are supported by recently published data,
where over-expression of both SR-A3 and SR-A5 in HeLa cells resulted
in increased uptake of CPP-plasmid nanocomplexes [22].
Surprisingly, SR-As were not exposed on the plasma membrane of
untreated cells, as observed with both TEM and confocal microscopy.
On the other hand, the receptors were nicely detectable inside the
cells in smaller vesicles or bound to membranous structures. SR-As are
trimeric transmembrane receptors, and we often found these labeled
with 2–3 nanogold tags in cells by immuno-TEM. However, upon treat-
ment of cells with PF14–SCO nanocomplexes the receptors translocated
to the plasmamembrane, where these clustered into bigger assemblies
that could contain up to 5–10nanogold particles, implying on theneces-
sity for SR-A clustering for induction of endocytosis.
SR-As are reported to be involved in the uptake of various bioactive
molecules, but less is known about their signaling and the mechanisms
that could be responsible for their targeting to the plasma membrane.
We speculate that calcium ions can be involved in this signaling, be-
cause calciumhave been described to activate some endocytic receptors[53]. In addition, it has been recently demonstrated that CPPs can mod-
ulate intracellular calcium levels or even cause an efﬂux of calcium into
the cytosol upon binding to the plasma membrane, after which mem-
brane repair response is triggered [54]. However, the exact role of calci-
um, if any, in targeting of SR-As to the plasma membrane needs to be
further examined. Alternatively, other pattern recognition receptors
that are expressed on the cell membrane, such as TLR2 and TLR4,
might be responsible for initial recognition and signaling to mobilize
SR-As to the cell surface. Amiel et al. have demonstrated that TLR2 and
TLR4, are expressed on the cell surface and and regulate SR-A-mediated
phagocytic uptake by MyD88 signaling [55]. Additionally, it has been
shown that lipopolysaccharide (LPS) stimulation promotes SR-A associ-
ationwith TLR4 [56]. Thus, it is feasible to speculate that, at least partial-
ly, TLR signaling might contribute to the mobilization of SR-As in the
presence of certain ligands. Several scavenger receptors including SR-
As were shown to function as heteromultimeric signaling complexes,
called signalosomes, with a wide range of transmembrane proteins
that include TLRs, integrins and tetraspanins [39]. It is not clearwhether
the association of scavenger receptors with other receptors is constitu-
tive or occurs only in response to exogenous ligands. However, the
fact that such association occurs only in the presence of exogenous li-
gandsmakes the systemmore ﬂexible allowing a ﬁnite number of scav-
enger receptors to contribute to different types of interactions only
when needed [39]; and this can explain our observation that their mo-
bilization to the cell surface occurs only in the presence of the
nanocomplexes.
In conclusion,we have characterized the cellular trafﬁcking of PF14–
SCO nanocomplexes in HeLa pLuc705 cells. First the association of the
nanocomplexes to SR-A3 and SR-A5 induces their internalization via
macropinocytosis and caveolin-mediated endocytosis. After internaliza-
tion, the complexes mainly localize in endocytic vesicles with near-
neutral pH that can be early endosomes and/or multivesicular bodies,
where from the nanocomplexes could escape to the cell cytosol. The
“naked” oligonucleotides, in contrary, were found to be trafﬁcked differ-
ently and these remained entrapped in endocytic vesicles. Finally, we
demonstrated the interaction of PF14–nucleic acid nanocomplexes
with SR-A receptors and that their colocalization was retained even in-
side the cells at least for 1 h; and that for the internalization only a few
trimeric receptors were needed. Surprisingly, SR-A3 and SR-A5 were
not exposed on the plasma membrane of untreated HeLa cells, but the
treatment with nanocomplexes induced their translocation to the cell
surface. Whether other pattern recognition receptors might also be in-
volved in this process is not clear and warrants further examination.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2015.09.019.
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